Orthopaedic Devices Panel Recommends Reclassification Of Pedicle Screw Spinal Systems
This article was originally published in The Gray Sheet
Executive Summary
FDA’s Orthopaedic and Rehabilitation Devices Panel recommended the downclassification of pedicle screw spinal systems from class III to class II at a May 22 meeting.
You may also be interested in...
Clinical Studies Needed For Nonthermal Shortwave Diathermy Devices, FDA Panel Says
The Orthopaedic and Rehabilitation Advisory Panel recommended FDA require a randomized, sham-control study design with a well-defined patient population to prove safety and effectiveness for the devices. The agency is currently considering whether to retain the preamendments device category in class III or downclassify to class II.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.